• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Bovie Medical settles lawsuit with former exec for $400k

Bovie Medical settles lawsuit with former exec for $400k

December 2, 2013 By Brad Perriello

Bovie Medical settles lawsuit with former exec for $400k

Bovie Medical (NYSE:BVX) said it reached a new settlement with a former executive that puts to bed a long-running lawsuit for $400,000.

Melville, N.Y.-based Bovie said it agreed to pay Steven Livneh, the former head of the Bovie Canada arm it formed after acquiring Lican Developments for $350,000 in cash in 2006, some $400,000 to settle the lawsuit.

That’s a drop from a prior settlement that would have seen the medical device company shell out $668,000 to Livneh.

The settlement calls for Bovie to pay out the $400,000 in 6 installments starting Dec. 10 and ending May 24, 2014, according to a regulatory filing.

Bovie will also upgrade an Icon VS generator it sold to Livneh, sell him another 3 Icon VS devices "designated as ‘not for human use,’" plus 150 generators for use on humans and "provide Livneh with various information relating to the Icon VS generator," according to the filing.

The deal also calls for Bovie to issue an exclusive license to Livneh to sell its Seal-N-Cut device in China and a non-exclusive license to sell the Seal-N-Cut outside of the People’s Republic. Each party will pay the other a 3% royalty on sales of the device, according to the filing.

Filed Under: Legal News, News Well, Surgical Tagged With: Bovie Medical Corp.

More recent news

  • Abbott partners with Berry Street to add nutrition coaching to Lingo
  • GE HealthCare taps retiring AT&T CFO for board of directors
  • Corcym delivers first-in-human implant of Memo 4D Curve mitral repair ring
  • Boston Scientific MedSurg, Asia Pacific leader to retire
  • DePuy Synthes launches next-generation automated fracture fixation system

Primary Sidebar

Cart

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy